1. Home
  2. FSUN vs GOSS Comparison

FSUN vs GOSS Comparison

Compare FSUN & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FSUN

FirstSun Capital Bancorp

HOLD

Current Price

$38.93

Market Cap

966.0M

Sector

Finance

ML Signal

HOLD

Logo Gossamer Bio Inc.

GOSS

Gossamer Bio Inc.

HOLD

Current Price

$2.51

Market Cap

796.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FSUN
GOSS
Founded
1892
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
966.0M
796.2M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
FSUN
GOSS
Price
$38.93
$2.51
Analyst Decision
Buy
Strong Buy
Analyst Count
3
6
Target Price
$46.33
$8.60
AVG Volume (30 Days)
100.0K
5.0M
Earning Date
01-26-2026
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
3.52
N/A
EPS
3.16
N/A
Revenue
$384,497,000.00
$44,051,000.00
Revenue This Year
$19.09
N/A
Revenue Next Year
$62.50
$6.41
P/E Ratio
$12.27
N/A
Revenue Growth
10.48
N/A
52 Week Low
$29.95
$0.76
52 Week High
$45.32
$3.87

Technical Indicators

Market Signals
Indicator
FSUN
GOSS
Relative Strength Index (RSI) 57.37 38.33
Support Level $37.73 $2.44
Resistance Level $39.57 $2.69
Average True Range (ATR) 0.92 0.21
MACD -0.09 -0.05
Stochastic Oscillator 56.99 17.00

Price Performance

Historical Comparison
FSUN
GOSS

About FSUN FirstSun Capital Bancorp

Firstsun Capital Bancorp is the financial holding company. It provides a full range of deposit, lending, treasury management, wealth management, and online banking products and services. The company operates in two segments - Banking operations and mortgage operations, the majority of which are generated by the banking operations segment. The Banking segment originates loans and provides deposits and fee based services to consumer, business, and mortgage lending customers. Products offered include a full range of commercial and consumer banking and financial services. The Mortgage Operations segment originates, sells, services, and manages market risk from changes in interest rates on one-to-four family residential mortgage loans.

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

Share on Social Networks: